Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Long-Term Deferred Tax (2021 - 2025)

Nutex Health (NUTX) has disclosed Long-Term Deferred Tax for 5 consecutive years, with $12.9 million as the latest value for Q2 2025.

  • For Q2 2025, Long-Term Deferred Tax changed N/A year-over-year to $12.9 million; the TTM value through Jun 2025 reached $12.9 million, changed N/A, while the annual FY2024 figure was $8.0 million, N/A changed from the prior year.
  • Long-Term Deferred Tax hit $12.9 million in Q2 2025 for Nutex Health, up from $10.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $12.9 million in Q2 2025 and bottomed at $2.4 million in Q3 2022.
  • Average Long-Term Deferred Tax over 4 years is $5.0 million, with a median of $2.4 million recorded in 2021.
  • Year-over-year, Long-Term Deferred Tax surged 99.8% in 2021 and then plummeted 38.53% in 2022.
  • Nutex Health's Long-Term Deferred Tax stood at $3.9 million in 2021, then crashed by 38.53% to $2.4 million in 2022, then skyrocketed by 232.79% to $8.0 million in 2024, then surged by 60.91% to $12.9 million in 2025.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $12.9 million, $10.5 million, and $8.0 million for Q2 2025, Q1 2025, and Q4 2024 respectively.